GoPath Diagnostics launched ProstateNow, a germline test for prostate cancer combining multi-gene analysis with a risk-focused approach to support real-world decision-making.
Public source
Publisher name
Public post
Many urology and oncology practices now integrate germline testing into prostate cancer care, especially for high‑risk, advanced, or strong family‑history cases. Prostat…
Company
GoPath Diagnostics
Improving the lives of those affected — or not yet affected — by cancer or other medical conditions.
- Industry
- Medical and Diagnostic Laboratories
- Location
- Buffalo Grove, US
- Company size
- 51–200 employees
About GoPath Diagnostics
Passionate about advancing cancer diagnostics, GoPath Diagnostics is a leading full-service laboratory specializing in cancer genetics, molecular, and anatomic pathology. Our cutting-edge technologies, global partnerships, and innovative solutions—GeneticsNow, OncoTarget, and OncoTracking—empower healthcare decisions. Proudly based in Buffalo Grove, IL, our comprehensive services encompass IHC, FISH, PCR testing, flow cytometry, cytogenetics, micro-array, and NGS. Join us in the fight against cancer!
See moreLatest activity
Latest activity from GoPath Diagnostics
3 signals
Presence & Recognition
GoPath Diagnostics is marking Prostate Cancer Awareness Month with a new video series called Know Your Risk featuring Dr. Brian Helfand.
Products & Services
GoPath Diagnostics launched ProstateNow, a prostate-focused germline test designed to assess prognosis, therapeutic options, and inherited risk in patients and high-risk families.
Discover more
Similar signals
Similar public activity from other companies.
Products & Services
Myriad Genetics
Myriad Genetics launched the Prolaris + AI Test, a personalized prostate cancer test that provides insights about an individual's prostate cancer to help patients and providers navigate active surveillance, treatment, and what comes next.
Products & Services
Astrin Biosciences
Astrin Biosciences released Certitude™, a blood-based test using deep proteomic analysis to identify breast cancer-associated protein signals in the blood.
Products & Services
Molecular Testing Labs
Molecular Testing Labs launched a comprehensive hormone testing portfolio including 11 individually orderable biomarkers and 5 clinically curated panels for women, fertility, perimenopause, postmenopause, and men's health.
Products & Services
OncoOptima
OncoOptima launched OncoChoice, a drug activity test measuring how a patient's own cancer cells respond to specific treatments, reporting cell-activity data back to the ordering physician.
Products & Services
NeoGenomics Laboratories